In March 2025, the company introduced new strategies to get a direct-to-purchaser presenting of its Wegovy weight loss drug. The company proven a brand new pharmacy, identified as NovoCare, which might cost consumers $499 per month for entry to the drug, fewer than 50 % the expense of the drug as a result of other pharmaceutical distribution networ